Epidemiology


Etiology

Predisposing factors

  • Nulliparity
  • Early menarche (< 10 years of age)
  • Age: 25–45 years
    • Fibroids are largely found in women of reproductive age.
    • Influenced by hormones (i.e., estrogen, growth hormone, and progesterone)
    • During menopause, hormone levels begin to decrease and leiomyomas begin to shrink.
  • Increased incidence in African American individuals

Pathophysiology


Clinical features

Symptoms depend on the number, size, and location of leiomyomas. Most women have small, asymptomatic fibroids.

  • Abnormal menstruation (possibly associated with anemia): hypermenorrhea, heavy menstrual bleeding, metrorrhagia, dysmenorrhea
    • Submucosal leiomyomas are most frequently associated with significantly prolonged or heavy menstrual bleeding. The mechanism may be related to the increased total surface area as a result of the bulging uterine wall, impaired uterine wall contractility, or micro/macrovascular abnormalities.
  • Features of mass effect
    • Enlarged, firm and irregular uterus during bimanual pelvic examination
      • Size can range from normal to full-term gestation
      • Differ from Adenomyosis, which shows globular, uniformly enlarged uterus that is soft but tender on palpation
    • Back or pelvic pain/discomfort
    • Urinary tract or bowel symptoms (e.g., urinary frequency/retention/incontinence, constipation, features of hydronephrosis)
  • Reproductive abnormalities
    • Infertility (difficulty conceiving and increased risk of pregnancy loss)
      • Related to an obstructed uterine cavity and/or impaired contractility of the uterus.
    • Dyspareunia

Diagnostics

Warning

Uterine leiomyomas are extremely common (affecting 70% of women) and are often found incidentally on ultrasound; do not attribute abnormal uterine bleeding to leiomyomas until other etiologies have been ruled out!

Pathology

  • Macroscopic
    • Grayish-white surface
    • Homogeneous; tissue bundles on cross-section partly in a whorled pattern
    • Some leiomyomas may involve regressive changes: scar formation, calcification, and cysts
  • Microscopic: Smooth muscle tissue in a whorled pattern with well-demarcated borders, consisting of monoclonal cells interspersed with connective tissue

Differential diagnostics


Pasted image 20240419083604.png

Uterine leiomyosarcoma (uterine sarcoma)

Rare malignant tumor arising from the smooth muscle cells of the myometrium

  • Risk factors
    • Menopause
    • Tamoxifen use
      • Because it stimulate the ER on uterine myometrium
  • Uterine findings
    • Rapidly enlarging
  • Pathology
    • Single lesions with areas of coagulative necrosis and/or hemorrhage
    • Cords of polygonal cells with eosinophilic cytoplasm, abundant mitoses, and cellular atypia are common.

Treatment